BioPharma Services Expands into Late-Stage Trials
Company Announcements

BioPharma Services Expands into Late-Stage Trials

Story Highlights

MCI Onehealth Technologies, Inc. Class A (TSE:AIDX) has released an update.

BioPharma Services, a subsidiary of HEALWELL AI Inc., is advancing its clinical research capabilities by moving into late-stage patient trials and integrating with AI technology. This strategic development transforms BioPharma into a full-service Contract Research Organization, supporting HEALWELL’s vision for growth and innovation in healthcare.

For further insights into TSE:AIDX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskPentavere AI Celebrates Third Prix Galien Nomination
TipRanks Canadian Auto-Generated NewsdeskOceanMD and Intrahealth Forge Path to Integrated Healthcare
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App